These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36854455)

  • 1. Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study.
    Aubert CE; Blum MR; Gastens V; Dalleur O; Vaillant F; Jennings E; Aujesky D; Thompson W; Kool T; Kramers C; Knol W; O'Mahony D; Rodondi N
    CMAJ Open; 2023; 11(1):E170-E178. PubMed ID: 36854455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.
    Nguyen-Soenen J; Rat C; Gaultier A; Schirr-Bonnans S; Tessier P; Fournier JP
    BMC Health Serv Res; 2022 Feb; 22(1):219. PubMed ID: 35177042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Implementation of a Pharmacist-Led Proton Pump Inhibitor Deprescribing Algorithm in a Geriatric Ambulatory Office.
    Leszcynski L; Bente J
    Sr Care Pharm; 2023 Mar; 38(3):105-112. PubMed ID: 36803698
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System.
    Mafi JN; May FP; Kahn KL; Chong M; Corona E; Yang L; Mongare MM; Nair V; Reynolds C; Gupta R; Damberg CL; Esrailian E; Sarkisian C
    J Am Geriatr Soc; 2019 Dec; 67(12):2600-2604. PubMed ID: 31486549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and Provider Perspectives on Deprescribing Proton Pump Inhibitors.
    Ikeji C; Williams A; Hennawi G; Brandt NJ
    J Gerontol Nurs; 2019 Oct; 45(10):9-17. PubMed ID: 31560071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial.
    Blum MR; Sallevelt BTGM; Spinewine A; O'Mahony D; Moutzouri E; Feller M; Baumgartner C; Roumet M; Jungo KT; Schwab N; Bretagne L; Beglinger S; Aubert CE; Wilting I; Thevelin S; Murphy K; Huibers CJA; Drenth-van Maanen AC; Boland B; Crowley E; Eichenberger A; Meulendijk M; Jennings E; Adam L; Roos MJ; Gleeson L; Shen Z; Marien S; Meinders AJ; Baretella O; Netzer S; de Montmollin M; Fournier A; Mouzon A; O'Mahony C; Aujesky D; Mavridis D; Byrne S; Jansen PAF; Schwenkglenks M; Spruit M; Dalleur O; Knol W; Trelle S; Rodondi N
    BMJ; 2021 Jul; 374():n1585. PubMed ID: 34257088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital admission as a deprescribing triage point for patients discharged to Residential Aged Care Facilities.
    Roberts G; Pegoli M; Grzeskowiak L; Benger S; Forbes H; Hunt K; Jafari S; Koeper I; McDonald C; Nguyen H; Rawther K; Taeuber L; Tran E; Vu P; Wisdom A; Russell P
    Age Ageing; 2021 Sep; 50(5):1600-1606. PubMed ID: 34036308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inappropriate proton-pump inhibitor prescribing in primary care - an observational study with quality circles.
    Vidonscky Lüthold R; Henz NC; Fuhrer C; Häner A; Schenk M; Jungo KT; Streit S
    Swiss Med Wkly; 2023 Sep; 153():40119. PubMed ID: 37769322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors.
    Reeve E; Andrews JM; Wiese MD; Hendrix I; Roberts MS; Shakib S
    Ann Pharmacother; 2015 Jan; 49(1):29-38. PubMed ID: 25385826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project.
    Calvo LLJ; García Cámara P; Llorente Barrio M; Sierra Gabarda O; Monzón Baez R; Arbonés Mainar JM; Alcedo González J; Bernal Monterde V
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1927-1933. PubMed ID: 34269841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the deprescribing guidelines for proton pump inhibitors in palliative care applicable? A monocentric observational study.
    Evin A; Denis C; Nizet P; Denis R; Lannes M; Victorri-Vigneau C; Huon JF
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e928-e932. PubMed ID: 37595979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
    Dharmarajan TS
    J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. We have had a gutful: The need for deprescribing proton pump inhibitors.
    Naunton M; Peterson GM; Deeks LS; Young H; Kosari S
    J Clin Pharm Ther; 2018 Feb; 43(1):65-72. PubMed ID: 28895169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (De)Prescribing of proton pump inhibitors: what has changed in recent years? an observational regional study from the French health insurance database.
    Gendre P; Mocquard J; Artarit P; Chaslerie A; Caillet P; Huon JF
    BMC Prim Care; 2022 Dec; 23(1):341. PubMed ID: 36582006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial.
    McCarthy C; Clyne B; Boland F; Moriarty F; Flood M; Wallace E; Smith SM;
    PLoS Med; 2022 Jan; 19(1):e1003862. PubMed ID: 34986166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprescribing in a family health team: a study of chronic proton pump inhibitor use.
    Walsh K; Kwan D; Marr P; Papoushek C; Lyon WK
    J Prim Health Care; 2016 Jun; 8(2):164-71. PubMed ID: 27477559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of the long-term use of proton pump inhibitors by a patient-oriented electronic decision support tool (arriba-PPI): study protocol for a randomized controlled trial.
    Rieckert A; Becker A; Donner-Banzhof N; Viniol A; Bücker B; Wilm S; Sönnichsen A; Barzel A
    Trials; 2019 Nov; 20(1):636. PubMed ID: 31752978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
    Moriarty F; Bennett K; Cahir C; Fahey T
    J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.